Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2017 | Biomarker testing in NSCLC

Keith Kerr • 5 May 2017
ELCC 2017
Lung Cancer

Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, UK discusses the multitude of biomarker tests available for the treatment of non-small cell lung cancer (NSCLC). Dr Kerr explains how these tests can identify the best treatment options for patients. This interview was recorded at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland.

More from Keith Kerr

2:55
Challenges of biomarker testing in the UK
Keith Kerr • 26 Apr 2023
3:32
Biomarker testing for ADCs
Keith Kerr • 27 Apr 2023
2:16
Pathology training in the molecular era
Keith Kerr • 24 Jan 2019
2:14
Pathology practice, an ever-changing field as more biomarkers emerge
Keith Kerr • 24 Jan 2019

Related Videos

3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
2:09
Is there a role for radiotherapy in extensive-stage SCLC?
Clive Peedell • 18 Apr 2024
3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
1:03
The benefits of liquid biopsies for lung cancer in the community setting
Deepti Behl • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals